Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2022-04-14 00:00:00 ET · period of report 2022-04-13 · accession 0001567619-22-008576 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-14 | 2022-04-13 | BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Off | S - Sale | $82.47 | -1,180 | 55.1K | -2% | -$97.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-13 | S | D | 1,180 | $82.47 | 55,077 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on February 28, 2022. |